# Program 1 Architecture Review Track Phase J - Non-Production Architecture Review Closure and Implementation Hold Renewal

Status: documentation-only, synthetic-only, non-production, non-runtime, conceptual, closure-only, implementation-hold renewal only.

## Purpose

Program 1 Architecture Review Track Phase J closes Architecture Review Track Phases A through I, summarizes the conceptual boundaries established across the track, records unresolved blockers, renews the pre-implementation hold, and explicitly states that no implementation, runtime access, integration, production readiness, clinical deployment, real-data processing, PHI/PII processing, approval/clearance/override capability, or go-live is authorized.

Phase J is not Phase Z+1, is not a return to the Phase V-Z governance/prototype sequence, is not an implementation authorization, is not a production-readiness review, is not a clinical deployment review, is not a go-live review, is not a real-data approval, is not a PHI/PII approval, is not an integration approval, and is not an approval/clearance/override implementation.

Program 1 remains in pre-implementation hold.

## Track closure

Phase J closes the Architecture Review Track from Phase A through Phase I as documentation-only and synthetic-only architecture review. No future phase or implementation track is started by Phase J.

## Scope

- Phase A through I closure index.
- Architecture boundary summary.
- Unresolved blocker register.
- Deferred capability register.
- Implementation hold renewal record.
- Future track decision criteria.
- Explicit non-approval statement.

## Non-scope

Phase J does not add runtime code, tests, helpers, scripts, imports, services, database migrations, API endpoints, UI flows, schedulers, task runners, integrations, connectors, API clients, database clients, EHR/EMR connectors, patient portal connectors, appointment system connectors, messaging system connectors, external system adapters, data connectors, real-data ingestion, PHI/PII processing, deployment automation, CI/CD workflow, infrastructure files, environment configuration, secrets, credentials, keys, tokens, read-only runtime access, database queries, EHR/EMR access, clinical decision execution, autonomous diagnosis, autonomous treatment, patient instruction delivery, runtime auth/authz/RBAC, runtime audit logging, patient messaging, appointment mutation, workflow enforcement, Task engine, Outcome Evidence, clinical write workflows, approval/clearance/override runtime capability, production-readiness claim, go-live authorization, or implementation track authorization.

## Safety boundaries

No production approval, implementation approval, real patient data approval, PHI/PII processing approval, privacy/legal clearance, integration approval, connector approval, API approval, database access approval, EHR/EMR access approval, patient portal access approval, appointment system access approval, messaging system access approval, deployment approval, release approval, or go-live authorization is granted by Phase J.

## Phase A through I closure index

| Phase | Phase purpose | Primary boundary established | Current status | Runtime behavior added | Real-data / PHI / PII approval added | Production approval added | Implementation authorization added | Resulting decision |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Phase A | Synthetic-only pre-implementation architecture boundary | Synthetic-only architecture review | Complete | No | No | No | No | Closed as docs-only |
| Phase B | Conceptual module separation and prohibited coupling map | Module separation and prohibited coupling | Complete | No | No | No | No | Closed as docs-only |
| Phase C | Conceptual data flow and synthetic boundary trace | Conceptual data-flow boundary | Complete | No | No | No | No | Closed as docs-only |
| Phase D | Conceptual read-only reference boundary and non-mutation model | Read-only concept and non-mutation | Complete | No | No | No | No | Closed as docs-only |
| Phase E | Human-in-the-loop responsibility and clinical accountability boundary | Human responsibility and clinical accountability | Complete | No | No | No | No | Closed as docs-only |
| Phase F | Security, authorization, and audit conceptual boundary | Security/auth/audit concepts | Complete | No | No | No | No | Closed as docs-only |
| Phase G | Privacy, PHI/PII, and real-data governance conceptual boundary | Privacy and real-data prohibitions | Complete | No | No | No | No | Closed as docs-only |
| Phase H | Deployment, environment, and release governance conceptual boundary | Deployment and release prohibitions | Complete | No | No | No | No | Closed as docs-only |
| Phase I | Integration, connector, and external system boundary | Integration and connector prohibitions | Complete | No | No | No | No | Closed as docs-only |

## Architecture boundary summary

- Synthetic-only boundary: only synthetic, abstract, non-patient examples may be discussed.
- Module separation boundary: conceptual modules remain separate from runtime code and real systems.
- Conceptual data-flow boundary: data flows are text-only, non-runtime, non-executable, and synthetic-only.
- Read-only conceptual boundary: read-only remains a future concept, not runtime access.
- Non-mutation boundary: Program 1 does not create, update, delete, transmit, route, assign, approve, override, clear, validate, deploy, or enforce clinical or operational objects.
- Human-in-the-loop boundary: human oversight remains a future conceptual requirement, not an implemented clinical model.
- Clinical accountability boundary: clinical accountability remains unresolved and future-review dependent.
- Security/auth/audit conceptual boundary: runtime security, authorization, RBAC, audit capture, and policy enforcement remain prohibited.
- Privacy/PHI/PII/real-data boundary: real-data and PHI/PII processing remain prohibited and not approved.
- Deployment/environment/release boundary: deployment, environments, release automation, rollback, monitoring, incident automation, and go-live remain prohibited.
- Integration/connector/external system boundary: integrations, connectors, APIs, external systems, EHR/EMR, databases, portals, appointment systems, and messaging systems remain prohibited.

## Unresolved blocker register

| Blocker | Status | Why unresolved | Prohibited now | Required future review | Phase J resolves it? | Current decision |
| --- | --- | --- | --- | --- | --- | --- |
| Implementation authorization blocker | Active | No authorization to leave hold | Runtime implementation | Explicit hold-exit authorization | No | Blocked |
| Production approval blocker | Active | No production governance approval | Production use | Production governance review | No | Blocked |
| Real-data approval blocker | Active | No real-data governance approval | Real-data processing | Data governance review | No | Blocked |
| PHI/PII processing blocker | Active | No privacy/legal approval | PHI/PII processing | Privacy/legal review | No | Blocked |
| Privacy/legal clearance blocker | Active | No legal/privacy clearance | Privacy clearance claims | Privacy/legal review | No | Blocked |
| Clinical safety blocker | Active | No clinical safety validation | Clinical deployment | Clinical safety review | No | Blocked |
| Clinical accountability blocker | Active | No accountability model | Clinical workflow execution | Clinical accountability review | No | Blocked |
| Runtime authorization/RBAC blocker | Active | No auth architecture implementation | Runtime auth/RBAC | Security architecture review | No | Blocked |
| Runtime audit blocker | Active | No audit implementation | Audit capture/logging | Audit architecture review | No | Blocked |
| Integration/connector blocker | Active | No integration authorization | APIs/connectors/external systems | Integration architecture review | No | Blocked |
| Deployment/environment blocker | Active | No deployment authorization | Environments/infrastructure | Deployment governance review | No | Blocked |
| Release/go-live blocker | Active | No release/go-live approval | Release/go-live | Release and production governance review | No | Blocked |
| Patient messaging blocker | Active | Patient communication prohibited | Patient messaging | Patient communication governance | No | Blocked |
| Appointment mutation blocker | Active | Scheduling mutation prohibited | Appointment mutation | Appointment governance review | No | Blocked |
| Clinical write workflow blocker | Active | Clinical writes prohibited | Clinical write workflows | Clinical safety and accountability review | No | Blocked |
| Workflow enforcement blocker | Active | Enforcement prohibited | Workflow enforcement | Workflow governance review | No | Blocked |
| Task engine blocker | Active | Task engine prohibited | Task engine | Workflow governance review | No | Blocked |
| Outcome Evidence blocker | Active | Outcome Evidence prohibited | Outcome Evidence | Outcome governance review | No | Blocked |
| Approval/clearance/override blocker | Active | Approval/override capability prohibited | Approval/clearance/override capability | Governance authorization | No | Blocked |

## Deferred capability register

Each deferred capability below is not implemented, not approved, not partially enabled, not available through Phase J, and requires a separately authorized future track before consideration:

- Runtime implementation.
- Read-only runtime access.
- Real-data processing.
- PHI/PII processing.
- Privacy tooling.
- De-identification/anonymization/pseudonymization tooling.
- Auth/authz/RBAC.
- Audit logging.
- Policy enforcement.
- Patient messaging.
- Appointment mutation.
- Task engine.
- Outcome Evidence.
- Workflow enforcement.
- Clinical write workflows.
- Integrations/connectors/APIs.
- Database/EHR/EMR access.
- Patient portal access.
- Deployment automation.
- CI/CD.
- Infrastructure.
- Monitoring/alerting.
- Production deployment.
- Approval/clearance/override capability.
- Go-live.

## Implementation hold renewal record

Program 1 cannot move into implementation, runtime access, real-data processing, clinical workflow execution, deployment planning, integration work, or go-live planning without a new explicit future authorization.

Phase J renews the pre-implementation hold. It does not create any path for automatic implementation or approval.

## Future track decision criteria

Any future track must explicitly state whether it is documentation-only, synthetic-only, pre-implementation, implementation-proposing, or implementation-authorized.

No future implementation track is authorized by Phase J.

Any future implementation-proposing or implementation-authorized track would require explicit authorization to leave pre-implementation hold, privacy/legal review, PHI/PII governance review, real-data governance review, clinical safety review, clinical accountability review, security architecture review, authorization/RBAC architecture review, audit architecture review, integration architecture review, deployment governance review, rollback/incident response review, validation evidence model, and production governance review before opening.

## Explicit non-approval statement

Phase J does not approve implementation, production use, real-data use, PHI/PII processing, clinical deployment, go-live, runtime data flow, read-only runtime access, database access, EHR/EMR access, patient portal access, appointment system access, messaging system access, integrations, connectors, APIs, deployment, CI/CD, infrastructure, runtime authorization, runtime audit logging, patient messaging, appointment mutation, workflow enforcement, clinical write workflows, Task engine, Outcome Evidence, or approval/clearance/override capability.

## Next-step decision

Do not automatically start another architecture phase.

Suggested next action: `Program 1 Architecture Review Track - Post-Closure Verification and Remote Synchronization`, or a new separate track only after explicit authorization.

## Closure statement

Architecture Review Track Phase J closes Program 1 Architecture Review Track Phases A through I as docs-only, synthetic-only, non-production, non-runtime architecture review. Program 1 remains in renewed pre-implementation hold and no future phase or track is started.
